Skip to content
DraconiticResearch
Search Sources API
179,152 studies31 sourcesUpdated 10 min ago
Peer-reviewedCC BY 4.0ACS Central Science

Ninhydrin as a Covalent Warhead for Chemical Proteomic-Enabled Discovery and Selective Engagement of Reactive Arginines

  1. 1University of California, San Francisco , , , ,
  2. 2Scripps Research Institute , , , ,

Abstract

Covalent molecules have emerged as next-generation therapeutics and as powerful tools for perturbing fundamental biological processes. Chemical proteomic methods to screen for reactive proteinaceous amino acids have transformed small-molecule discovery pipelines, but their application remains mostly limited to sites where reactive cysteines and lysines are present. Here we report a ninhydrin-based warhead that selectively modifies arginine residues, thus expanding the repertoire of amino acids targetable by covalent molecules. Specifically, we developed alkyne-functionalized variants of ninhydrin to establish an arginine-specific chemical proteomics platform, enabling the classification of more than 6,800 unique reactive arginines from one cell line. These studies uncovered potential modification sites on disease-relevant proteins, including reactive arginines within catalytic sites that are essential for function and reactive arginines on proteins lacking reactive cysteines. By endowing a reversible small-molecule binder of cyclophilin A with a ninhydrin warhead, we achieved selective, covalent engagement in cell lysates and attenuation of enzymatic activity in vitro. These findings establish ninhydrin as a warhead for studying arginine reactivity and identifying at scale arginines amenable to covalent modification.

Related

  1. Beyond the catalytic serine: selective protease engagement with covalent macrocyclic activity-based probes
    Marina Barrueco, Ellie Hyde, Ella Sawtell +6
    Chemical sciencePeer-reviewedCC BYFull textOrganic chemistryEurope PMC
  2. Coumarin–Ferulic Acid Hybrid Mediates HT-29-Selective Growth Inhibition and Proteomic Profiling
    Sucheewin Krobthong, Meng Chieh Yang, Pattarawit Rukthong +3
    MoleculesPeer-reviewedCC BY 4.0Full textOrganic chemistryCrossrefEurope PMC
  3. Discovery of selective, metabolically stable pyrazole-based FLT3 inhibitors for the treatment of acute myeloid leukemia
    Lorenza Destro, Valentina Crippa, Daniela Gabbia +6
    RSC Medicinal ChemistryPeer-reviewedLicence not statedFull text2 citedGeneral chemistryHAL
  4. Descriptor-Based Regression Analysis Enables the Discovery of Highly Selective Ligands for Palladium-Catalyzed Siloxycyclopropanation
    Vishal Kumar Rawat, Ryoichi Tabata, Tetsuya Inagaki +4
    ChemRxivPreprintCC BY-NC-NDFull textOrganic chemistryChemRxiv
  5. In situ polymerized monolith tips for reproducible, format-flexible proteomic sample preparation applied to biofluids
    Kathrin Korff, Lukas T. Henneberg, Denys Oliinyk +9
    Molecular & Cellular ProteomicsPeer-reviewedCC BY 4.0Full textPhysical chemistryCrossref
BibTeX
@article{ecker2026ninhydrin,
  title = {{Ninhydrin as a Covalent Warhead for Chemical Proteomic-Enabled Discovery and Selective Engagement of Reactive Arginines}},
  author = {Andrew K. Ecker and Andreas Langen and Chloe S. Fields and José L. Montaño and Minh Tran and Ian B. Seiple and Balyn W. Zaro},
  journal = {ACS Central Science},
  year = {2026},
  month = sep,
  doi = {10.1021/acscentsci.6c00922},
  url = {https://pubs.acs.org/acscii/article/12/10/1610/5442588/Ninhydrin-as-a-Covalent-Warhead-for-Chemical},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Ninhydrin as a Covalent Warhead for Chemical Proteomic-Enabled Discovery and Selective Engagement of Reactive Arginines
AU  - Andrew K. Ecker
AU  - Andreas Langen
AU  - Chloe S. Fields
AU  - José L. Montaño
AU  - Minh Tran
AU  - Ian B. Seiple
AU  - Balyn W. Zaro
PY  - 2026
DA  - 2026/09/01
JO  - ACS Central Science
DO  - 10.1021/acscentsci.6c00922
UR  - https://pubs.acs.org/acscii/article/12/10/1610/5442588/Ninhydrin-as-a-Covalent-Warhead-for-Chemical
AB  - Covalent molecules have emerged as next-generation therapeutics and as powerful tools for perturbing fundamental biological processes. Chemical proteomic methods to screen for reactive proteinaceous amino acids have transformed small-molecule discovery pipelines, but their application remains mostly limited to sites where reactive cysteines and lysines are present. Here we report a ninhydrin-based warhead that selectively modifies arginine residues, thus expanding the repertoire of amino acids targetable by covalent molecules. Specifically, we developed alkyne-functionalized variants of ninhydrin to establish an arginine-specific chemical proteomics platform, enabling the classification of more than 6,800 unique reactive arginines from one cell line. These studies uncovered potential modification sites on disease-relevant proteins, including reactive arginines within catalytic sites that are essential for function and reactive arginines on proteins lacking reactive cysteines. By endowing a reversible small-molecule binder of cyclophilin A with a ninhydrin warhead, we achieved selective, covalent engagement in cell lysates and attenuation of enzymatic activity in vitro. These findings establish ninhydrin as a warhead for studying arginine reactivity and identifying at scale arginines amenable to covalent modification.
SN  - 2374-7943
SN  - 2374-7951
ER  -